help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCawley, L. J.
Right arrow Articles by Hudson, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCawley, L. J.
Right arrow Articles by Hudson, L. G.
Endocrinology Vol. 138, No. 1 121-127
Copyright © 1997 by The Endocrine Society


ARTICLES

Overexpression of the Epidermal Growth Factor Receptor Contributes to Enhanced Ligand-Mediated Motility in Keratinocyte Cell Lines1

Lisa J. McCawley, Patricia O’Brien and Laurie G. Hudson

Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Medical School, Chicago, Illinois 60611

Address all correspondence and requests for reprints to: Dr. Laurie G. Hudson, Department of Molecular Pharmacology and Biological Chemistry, Searle 8–565, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, Illinois 60611.

In keratinocytes, epidermal growth factor (EGF) promotes cell motility in addition to proliferation. As EGF receptor expression is elevated during wound healing and in many epithelial tumors, we wanted to investigate whether there is a direct relationship between EGF receptor expression and ligand-mediated cellular locomotion. EGF receptor activation induced cell migration in normal keratinocytes and their tumorigenic counterparts; however, the rate of colony dispersion and in vitro reepithelialization was more rapid in the squamous cell carcinoma (SCC) lines that exhibited elevated (>=5-fold) EGF receptor levels. Within a single SCC line, submaximal concentrations of EGF or reduction of EGF receptor activity by an anti-EGF receptor neutralizing antibody resulted in delayed kinetics of in vitro reepithelialization. Thus, suppression of EGF receptor activity in an overexpressing SCC line restores a migratory response that more closely resembles that of normal keratinocytes. Conversely, ligand-induced colony dispersion was augmented in stable clonal cell lines in which EGF receptor expression was elevated after introduction of an EGF receptor complementary DNA construct. Collectively, these findings suggest that the migratory potential of keratinocytes is modulated at the level of both receptor expression and ligand concentration, with a positive correlation between EGF receptor levels and ligand-induced cell motility.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
G. W. Neill, W. J. Harrison, M. S. Ikram, T. D.L. Williams, L. S. Bianchi, S. K. Nadendla, J. L. Green, L. Ghali, A.-M. Frischauf, E. A. O'Toole, et al.
GLI1 repression of ERK activity correlates with colony formation and impaired migration in human epidermal keratinocytes
Carcinogenesis, April 1, 2008; 29(4): 738 - 746.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Tokumaru, K. Sayama, Y. Shirakata, H. Komatsuzawa, K. Ouhara, Y. Hanakawa, Y. Yahata, X. Dai, M. Tohyama, H. Nagai, et al.
Induction of Keratinocyte Migration via Transactivation of the Epidermal Growth Factor Receptor by the Antimicrobial Peptide LL-37
J. Immunol., October 1, 2005; 175(7): 4662 - 4668.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
B. D. Harms, G. M. Bassi, A. R. Horwitz, and D. A. Lauffenburger
Directional Persistence of EGF-Induced Cell Migration Is Associated with Stabilization of Lamellipodial Protrusions
Biophys. J., February 1, 2005; 88(2): 1479 - 1488.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
R. C. Kurten, P. Chowdhury, R. C. Sanders Jr., L. M. Pittman, L. W. Sessions, T. C. Chambers, C. S. Lyle, B. J. Schnackenberg, and S. M. Jones
Coordinating epidermal growth factor-induced motility promotes efficient wound closure
Am J Physiol Cell Physiol, January 1, 2005; 288(1): C109 - C121.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. J. Barnes, R. Bagheri-Yarmand, M. Mandal, Z. Yang, G. L. Clayman, W. K. Hong, and R. Kumar
Suppression of Epidermal Growth Factor Receptor, Mitogen-activated Protein Kinase, and Pak1 Pathways and Invasiveness of Human Cutaneous Squamous Cancer Cells by the Tyrosine Kinase Inhibitor ZD1839 (Iressa)
Mol. Cancer Ther., April 1, 2003; 2(4): 345 - 351.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Kari, T. O. Chan, M. Rocha de Quadros, and U. Rodeck
Targeting the Epidermal Growth Factor Receptor in Cancer: Apoptosis Takes Center Stage
Cancer Res., January 1, 2003; 63(1): 1 - 5.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Kottke, A. L. Blajeski, L. M. Martins, P. W. Mesner Jr., N. E. Davidson, W. C. Earnshaw, D. K. Armstrong, and S. H. Kaufmann
Comparison of Paclitaxel-, 5-Fluoro-2'-deoxyuridine-, and Epidermal Growth Factor (EGF)-induced Apoptosis. EVIDENCE FOR EGF-INDUCED ANOIKIS
J. Biol. Chem., May 28, 1999; 274(22): 15927 - 15936.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. K. Pilcher, J. Dumin, M. J. Schwartz, B. A. Mast, G. S. Schultz, W. C. Parks, and H. G. Welgus
Keratinocyte Collagenase-1 Expression Requires an Epidermal Growth Factor Receptor Autocrine Mechanism
J. Biol. Chem., April 9, 1999; 274(15): 10372 - 10381.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Zhao, A. Dick, J. V. Forrester, and C. D. McCaig
Electric Field-directed Cell Motility Involves Up-regulated Expression and Asymmetric Redistribution of the Epidermal Growth Factor Receptors and Is Enhanced by Fibronectin and Laminin
Mol. Biol. Cell, April 1, 1999; 10(4): 1259 - 1276.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. J. McCawley, S. Li, E. V. Wattenberg, and L. G. Hudson
Sustained Activation of the Mitogen-activated Protein Kinase Pathway. A MECHANISM UNDERLYING RECEPTOR TYROSINE KINASE SPECIFICITY FOR MATRIX METALLOPROTEINASE-9 INDUCTION AND CELL MIGRATION
J. Biol. Chem., February 12, 1999; 274(7): 4347 - 4353.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K. Fang, E Ionides, G Oster, R Nuccitelli, and R. Isseroff
Epidermal growth factor receptor relocalization and kinase activity are necessary for directional migration of keratinocytes in DC electric fields
J. Cell Sci., January 6, 1999; 112(12): 1967 - 1978.
[Abstract] [PDF]


Home page
JCBHome page
A. Malliri, M. Symons, R. F. Hennigan, A. F.L. Hurlstone, R. F. Lamb, T. Wheeler, and B. W. Ozanne
The Transcription Factor AP-1 Is Required for EGF-induced Activation of Rho-like GTPases, Cytoskeletal Rearrangements, Motility, and In Vitro Invasion of A431 Cells
J. Cell Biol., November 16, 1998; 143(4): 1087 - 1099.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-P. Pienimaki, K. Rilla, C. Fulop, R. K. Sironen, S. Karvinen, S. Pasonen, M. J. Lammi, R. Tammi, V. C. Hascall, and M. I. Tammi
Epidermal Growth Factor Activates Hyaluronan Synthase 2 in Epidermal Keratinocytes and Increases Pericellular and Intracellular Hyaluronan
J. Biol. Chem., June 1, 2001; 276(23): 20428 - 20435.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society